Gisela Backfisch

USPTO Granted Patents = 15 (Patent Applications = 9)

CIPO Patents = 2 (Patent Applications = 8)

EPO Patents = 9 (Patent Applications = 16)

Average Co-Inventor Count = 9.3

ph-index = 3

Forward Citations = 49(Granted Patents)

Location History:

Dossenheim, DE (2006 - 2013)
Wiesbaden, DE (2015)
Ludwigshafen, DE (2011 - 2017)

Company Filing History:

Abb Vie Deutschland Gmbh & Co. Kg

patents

4 out of 4,177

Abbott Laboratories Corporation

Abbvie Deutschland Gmbh and Co Kg

patents

where one patent can have more than one assignee

Years Active: 2006-2017

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9573950 - Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators (2017-02-21),

2. 9540376 - Hexahydrodiazepinoquinolines carrying a substituted alkyl radical (2017-01-10),

3. 9150553 - Carboxamide compounds and their use as calpain inhibitors (2015-10-06),

4. 9150545 - Carboxamide compounds and their use as calpain inhibitors V (2015-10-06),

5. 9062027 - Carboxamide compounds and their use as calpain inhibitors V (2015-06-23),

6. 9051304 - Carboxamide compounds and their use as calpain inhibitors V (2015-06-09),

7. 8598211 - Carboxamide compounds and their use as calpain inhibitors IV (2013-12-03),

8. 8470810 - Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor (2013-06-25),

9. 8362010 - [object Object] (2013-01-29),

10. 8343959 - N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor (2013-01-01),

11. 8183237 - [object Object] (2012-05-22),

12. 8101754 - [object Object] (2012-01-24),

13. 8076326 - [object Object] (2011-12-13),

14. 7851463 - [object Object] (2010-12-14),

15. 7144902 - Prodrugs of thrombin inhibitors (2006-12-05),

Title: Gisela Backfisch: Pioneering Sustainable Solutions Through Innovation

Introduction: Gisela Backfisch, a trailblazing inventor hailing from Ludwigshafen, DE, has left an indelible mark on the global technological landscape with her passion for innovation and dedication to creating a more sustainable world.

Latest Patents: Gisela Backfisch's latest patents showcase her expertise and commitment to advancing medical science. The patented inventions include compounds such as substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators, and hexahydrodiazepinoquinolines carrying a substituted alkyl radical. These inventions have significant implications for modulating the 5-HT2C receptor and treating various conditions and disorders effectively.

Career Highlights: With an impressive portfolio of 15 patents to her name, Gisela Backfisch has demonstrated exceptional ingenuity and creativity in the field of pharmaceuticals. Having worked at renowned companies like Abbott GmbH & Co. KG and AbbVie Deutschland GmbH & Co. KG, she has contributed immensely to cutting-edge research and development in the healthcare sector.

Collaborations: Throughout her career, Gisela Backfisch has collaborated with esteemed professionals like Andreas Haupt and Karla Drescher. These collaborations have not only enriched her work but have also led to groundbreaking innovations that have reshaped the industry.

Conclusion: Gisela Backfisch's dedication to innovation and sustainable solutions has solidified her legacy as a pioneering inventor. Her remarkable contributions to the field of pharmaceuticals continue to inspire future generations to push the boundaries of scientific exploration and make a lasting impact on the world.

This text is generated by artificial intelligence and may not be accurate.